FindTrial
Sign In

Effect of Atorvaastatin for preventing for coronary artery lesion in acute Kawasaki disease

Effect of Atorvaastatin for preventing for coronary artery lesion in acute Kawasaki disease - Effect of Atorvaastatin for acute Kawasaki disease

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000023105
Enrollment
30
Registered
2016-07-12
Start date
2016-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kawasaki disease

Interventions

atrvastatin 0.5mg/kg 2 weeks

Sponsors

Kitasato university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: above 2,5 Z score of coronary artery

Exclusion criteria

Exclusion criteria: coronary artery aneurysm

Design outcomes

Primary

MeasureTime frame
coronary artery echocardiography in 1 month after therapy—

Countries

Japan,North America

Contacts

Public ContactOgata syohei

Kitasato university pedoatrics

ishiim@med.kitasato-u.ac.jp0427788829

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026